Status:
UNKNOWN
Preoperative Administration of Lugols Solution in Toxic Thyroid Diseases (TD): A Prospective Study
Lead Sponsor:
Aristotle University Of Thessaloniki
Conditions:
Toxic; Thyroid
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Lugol's solution and other preparations containing iodide have been used as an adjuvant treatment in patients with toxic disease planned for thyroidectomy. However, no conclusive evidence supporting t...
Eligibility Criteria
Inclusion
- Patients ≥18 years of age
- Toxic thyroid disease, treated with antithyroid drugs, euthyroid and proposed for total thyroidectomy
- Written informed consent
Exclusion
- prior thyroid or parathyroid surgery,
- hyperparathyroidism that requires associated parathyroidectomy,
- thyroid cancer that requires adding a lymph node dissection,
- iodine allergy,
- consumption of lithium or amiodarone,
- medically unfit patients (ASA-IV),
- breastfeeding women,
- preoperative vocal cord palsy and
- planned endoscopic, video-assisted or remote access surgery.
Key Trial Info
Start Date :
December 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06176976
Start Date
December 15 2023
End Date
June 1 2025
Last Update
December 20 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
3rd Surgical Department of Aristotle University, AHEPA University Hospital, Thessaloniki
Thessaloniki, Thessaloniki, Greece, 54352